Spots Global Cancer Trial Database for lung neoplasm malignant
Every month we try and update this database with for lung neoplasm malignant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy | NCT05414188 | Lung Neoplasm M... | Pulmonary rehab... | 20 Years - | Asan Medical Center | |
Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis | NCT04036721 | Lung Neoplasm M... Interstitial Lu... | Prolonged gluco... Short glucocort... | 18 Years - | National Institute for Tuberculosis and Lung Diseases, Poland | |
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer | NCT04973293 | Lung Neoplasm M... | sintilimab bevacizumab | 18 Years - 75 Years | Ruijin Hospital | |
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years | NCT05404022 | Lung Neoplasm M... Mesothelioma; L... | Tailored nutrit... | 65 Years - | University of Hull | |
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors | NCT05013554 | Neoplasm Malign... Breast Cancer Lung Neoplasm M... Gastric Cancer Neoplasm | SAR443216 IV SAR443216 SC | 18 Years - | Sanofi | |
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer | NCT05974475 | Lung Neoplasm M... | SBRT Surgery | 18 Years - | European Institute of Oncology | |
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer | NCT05974475 | Lung Neoplasm M... | SBRT Surgery | 18 Years - | European Institute of Oncology | |
Confocal Laser Endomicroscopy VERification | NCT06079970 | Lung Cancer Lung Neoplasm M... Carcinoma, Non-... Neoplasm of Lun... | Neelde Based Co... Conventional di... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer | NCT02985203 | Lung Neoplasm M... | Vinorelbine Ora... | 18 Years - | Guangdong Association of Clinical Trials | |
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery | NCT03824977 | Lung Neoplasm M... Resectable Lung... | Six minutes ste... Sit to stand te... | 18 Years - | University Hospital, Rouen | |
Confocal Laser Endomicroscopy VERification | NCT06079970 | Lung Cancer Lung Neoplasm M... Carcinoma, Non-... Neoplasm of Lun... | Neelde Based Co... Conventional di... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer | NCT03352245 | Lung Neoplasm M... | Prescribed Acti... | 21 Years - | Yale University | |
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer | NCT02985203 | Lung Neoplasm M... | Vinorelbine Ora... | 18 Years - | Guangdong Association of Clinical Trials | |
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | NCT05241873 | Lung Neoplasm M... Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... EGFR Exon 20 Mu... EGFR Exon 20 In... EGFR Activating... Antineoplastic ... Metastatic Lung... Brain Metastase... EGFR-mutated NS... EGFR Atypical M... | BLU-451 Carboplatin Pemetrexed | 18 Years - | Blueprint Medicines Corporation | |
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC | NCT03525782 | Lung Neoplasm M... Non-small Cell ... | CAR-T Cells CAR-T combining... PD-1 knockout PD-1 mAb Sham control | 18 Years - 70 Years | The First Affiliated Hospital of Guangdong Pharmaceutical University | |
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years | NCT05404022 | Lung Neoplasm M... Mesothelioma; L... | Tailored nutrit... | 65 Years - | University of Hull | |
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer | NCT04973293 | Lung Neoplasm M... | sintilimab bevacizumab | 18 Years - 75 Years | Ruijin Hospital | |
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors | NCT05013554 | Neoplasm Malign... Breast Cancer Lung Neoplasm M... Gastric Cancer Neoplasm | SAR443216 IV SAR443216 SC | 18 Years - | Sanofi | |
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] | NCT04059887 | Lung Neoplasm M... | Atezolizumab In... | 18 Years - | Chonnam National University Hospital | |
Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer | NCT05890872 | Lung Neoplasm M... | Aliya Pulsed El... | 22 Years - | Galvanize Therapeutics, Inc. | |
Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy | NCT04778826 | Lung Neoplasm M... | Lymphadenectomy | 18 Years - | Otto Wagner Hospital |